{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:35Z","timestamp":1791856115720,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.contraception.2010.04.002","type":"journal-article","created":{"date-parts":[[2010,7,19]],"date-time":"2010-07-19T03:12:15Z","timestamp":1279509135000},"page":"276-280","source":"Crossref","is-referenced-by-count":60,"title":["Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"82","author":[{"given":"Vincenzo","family":"De Leo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Musacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Scolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.04.002_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"De Leo","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2010.04.002_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2010.04.002_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0010-7824(95)00098-U","article-title":"Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins","volume":"51","author":"Wiegratz","year":"1995","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2010.04.002_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.11.137","article-title":"Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome","volume":"88","author":"De Leo","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.04.002_bib5","first-page":"CD001125","article-title":"Cyproterone acetate for hirsutism","author":"Van der Spuy","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2010.04.002_bib6","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.04.002_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1783\/1471189041261636","article-title":"An observational study of Yasmin in the management of women with polycystic ovary syndrome","volume":"30","author":"Palep-Singh","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.04.002_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.002_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.002_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1529-8019.2008.00215.x","article-title":"Medical treatment of hirsutism","author":"Blume-Peytavi","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.contraception.2010.04.002_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrb\u00edkov\u00e1","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2010.04.002_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-7824(90)90034-S","article-title":"Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone","volume":"41","author":"Van der Vange","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.002_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00128071-200001020-00003","article-title":"Management of hirsutism","volume":"1","author":"Falsetti","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.contraception.2010.04.002_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/16.1.36","article-title":"Efficacy of the combination ethinyl oestradiol and cyproterone acetate on the endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome","volume":"16","author":"Falsetti","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.002_bib15","first-page":"131","article-title":"Sex hormone-binding globulin during treatment with various combined oral contraceptives","volume":"2","author":"Falsetti","year":"1988","journal-title":"Gynecol Obstet"},{"key":"10.1016\/j.contraception.2010.04.002_bib16","first-page":"65","article-title":"Effetti di 8 contraccettivi orali su SHBG, CBG, e testosterone libero","volume":"6","author":"Falsetti","year":"1989","journal-title":"Perspectives Gynecol Obstet"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T08:20:29Z","timestamp":1544343629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0010782410001393"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.04.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}